Nukkleus Performance

NUKKDelisted Stock  USD 2.06  0.11  5.64%   
The company secures a Beta (Market Risk) of 2.54, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nukkleus will likely underperform. At this point, Nukkleus has a negative expected return of -0.99%. Please make sure to verify Nukkleus' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Nukkleus performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Nukkleus has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Begin Period Cash Flow691.8 K
Total Cashflows From Investing Activities132.8 K
  

Nukkleus Relative Risk vs. Return Landscape

If you would invest  421.00  in Nukkleus on November 19, 2025 and sell it today you would lose (215.00) from holding Nukkleus or give up 51.07% of portfolio value over 90 days. Nukkleus is currently does not generate positive expected returns and assumes 7.9992% risk (volatility on return distribution) over the 90 days horizon. In different words, 71% of stocks are less volatile than Nukkleus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Nukkleus is expected to under-perform the market. In addition to that, the company is 10.5 times more volatile than its market benchmark. It trades about -0.12 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

Nukkleus Target Price Odds to finish over Current Price

The tendency of Nukkleus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.06 90 days 2.06 
over 95.74
Based on a normal probability distribution, the odds of Nukkleus to move above the current price in 90 days from now is over 95.74 (This Nukkleus probability density function shows the probability of Nukkleus Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.54 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Nukkleus will likely underperform. Additionally Nukkleus has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Nukkleus Price Density   
       Price  

Predictive Modules for Nukkleus

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nukkleus. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.101.999.92
Details
Intrinsic
Valuation
LowRealHigh
0.101.969.89
Details

Nukkleus Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Nukkleus is not an exception. The market had few large corrections towards the Nukkleus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nukkleus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nukkleus within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.59
β
Beta against Dow Jones2.54
σ
Overall volatility
1.40
Ir
Information ratio -0.19

Nukkleus Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nukkleus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nukkleus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Nukkleus is now traded under the symbol DFNS. Please update your portfolios or report it if you believe this is an error. Report It!
Nukkleus is not yet fully synchronised with the market data
Nukkleus generated a negative expected return over the last 90 days
Nukkleus has high historical volatility and very poor performance
Nukkleus has a very high chance of going through financial distress in the upcoming years
Nukkleus currently holds 4 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 5.91 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 998.52 K.
Nukkleus currently holds about 23.14 K in cash with (3.82 M) of positive cash flow from operations.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Nukkleus announces 10 million private placement - MSN

Nukkleus Fundamentals Growth

Nukkleus Stock prices reflect investors' perceptions of the future prospects and financial health of Nukkleus, and Nukkleus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nukkleus Stock performance.

About Nukkleus Performance

By examining Nukkleus' fundamental ratios, stakeholders can obtain critical insights into Nukkleus' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nukkleus is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd. Nukkleus operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 12 people.

Things to note about Nukkleus performance evaluation

Checking the ongoing alerts about Nukkleus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nukkleus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Nukkleus is now traded under the symbol DFNS. Please update your portfolios or report it if you believe this is an error. Report It!
Nukkleus is not yet fully synchronised with the market data
Nukkleus generated a negative expected return over the last 90 days
Nukkleus has high historical volatility and very poor performance
Nukkleus has a very high chance of going through financial distress in the upcoming years
Nukkleus currently holds 4 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 5.91 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 998.52 K.
Nukkleus currently holds about 23.14 K in cash with (3.82 M) of positive cash flow from operations.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Nukkleus announces 10 million private placement - MSN
Evaluating Nukkleus' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Nukkleus' stock performance include:
  • Analyzing Nukkleus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nukkleus' stock is overvalued or undervalued compared to its peers.
  • Examining Nukkleus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Nukkleus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nukkleus' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Nukkleus' stock. These opinions can provide insight into Nukkleus' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Nukkleus' stock performance is not an exact science, and many factors can impact Nukkleus' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Nukkleus Stock

If you are still planning to invest in Nukkleus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nukkleus' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges